- “Glimepiride + Metformin + Pioglitazone Tablets” already exists in your wishlist
In Stock
Losartan Tablets
Losartan Tablets 25mg | Cardiac / Hypertension
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
This document provides a concise, practical overview of losartan 25 mg in English. It covers product introduction, clinical uses, benefits, common and serious side effects, safety advice and precautions, mechanism of action (how it works), dosing and administration (how to use), quick practical tips for patients, and notable drug interactions. This information is intended for educational purposes and does not replace professional medical advice. Consult a physician or pharmacist before starting or changing therapy.
Product Introduction
Losartan is an angiotensin II receptor blocker (ARB) used primarily to treat high blood pressure (hypertension) and to help protect the kidneys in certain patients with type 2 diabetes and proteinuria. The 25 mg strength is a commonly used starting or maintenance dose, often adjusted according to response and clinical context. Losartan reduces the effects of angiotensin II, a hormone that narrows blood vessels and increases blood pressure. By blocking angiotensin II receptors, losartan lowers blood pressure, reduces strain on the heart, and can slow progression of kidney damage in selected patients.
Uses
-
Treatment of hypertension (high blood pressure) as monotherapy or in combination with other antihypertensives.
-
Reduction of risk of stroke in patients with hypertension and left ventricular hypertrophy (depending on patient profile and clinical guidelines).
-
Management to protect renal function in patients with type 2 diabetes with proteinuria (reduces progression of nephropathy).
-
Treatment of heart failure in some patients as part of guideline-directed medical therapy when ACE inhibitors are not tolerated.
Benefits
The main benefits of losartan include:
-
Effective lowering of blood pressure, which reduces risk of cardiovascular events such as heart attack and stroke.
-
Renal protection in patients with type 2 diabetes and proteinuria — it can reduce albuminuria and slow progression of chronic kidney disease.
-
Well tolerated oral therapy with once-daily dosing in many patients, improving adherence.
-
Lower incidence of certain side effects (for example, dry cough) compared with ACE inhibitors because its mechanism does not raise bradykinin levels.
Side Effects
Side effects are generally dose-related and many patients tolerate losartan well. Common and less common adverse effects include:
-
Common (may affect up to 1 in 10 people): dizziness, lightheadedness (especially on standing or after the first dose), fatigue.
-
Less common: nasal congestion, upper respiratory infection symptoms, gastrointestinal upset (nausea, abdominal pain).
-
Laboratory abnormalities: changes in kidney function (rise in serum creatinine) and electrolyte disturbances, particularly increased serum potassium (hyperkalemia).
-
Rare but serious: severe hypotension (especially in volume‑depleted patients), angioedema (rare but potentially life-threatening), significant kidney dysfunction, symptomatic hyperkalemia, and allergic reactions.
-
If any signs of angioedema (swelling of face, lips, tongue, or difficulty breathing), stop the medicine and seek emergency care immediately.
Safety Advice and Precautions
Before starting losartan, discuss the following with your healthcare provider or pharmacist:
-
Allergies and prior reactions: inform if you have had angioedema with any ARB or ACE inhibitor or other drug allergies.
-
Pregnancy and breastfeeding: Losartan is contraindicated during pregnancy because drugs that act on the renin–angiotensin system can cause fetal injury and death. Women of childbearing potential should use effective contraception and inform their physician if pregnancy is planned or suspected. Breastfeeding: discuss with your prescriber; alternative agents may be preferred.
-
Kidney function: losartan can alter renal function, particularly in patients with renal artery stenosis, volume depletion, or pre-existing renal impairment. Kidney function and electrolytes (serum creatinine and potassium) should be checked after starting therapy or after dose changes.
-
Electrolytes: monitor potassium levels if you have risk factors for hyperkalemia (e.g., chronic kidney disease, diabetes, use of potassium supplements, or potassium-sparing diuretics).
-
Low blood pressure risk: those who are dehydrated or taking diuretics may be at increased risk of symptomatic hypotension. Start at lower doses and monitor blood pressure closely.
-
Elderly patients: may be more sensitive to blood pressure–lowering effects; dose adjustments and monitoring recommended.
-
Concomitant conditions: use caution in bilateral renal artery stenosis, severe liver disease (dose adjustment may be needed), and heart failure patients on multiple agents.
How It Works
Losartan blocks the angiotensin II type 1 (AT1) receptor. Angiotensin II is a potent vasoconstrictor produced as part of the renin–angiotensin–aldosterone system (RAAS). By blocking AT1 receptors, losartan prevents angiotensin II from binding and exerting its effects, leading to:
-
Vasodilation (widening of blood vessels) and reduced systemic vascular resistance, which lowers blood pressure.
-
Reduced aldosterone secretion, decreasing sodium and water retention and potentially lowering blood volume.
-
Decreased glomerular hypertension and reduced protein filtration into urine in certain diabetic patients, contributing to renal protection.
How to Use (Dosing and Administration)
Dosing must be individualized by the prescriber. The following are general guidance points; follow your doctor’s instructions.
-
Typical adult starting dose for hypertension: often 25 mg to 50 mg once daily. Losartan 25 mg may be used as a starting dose in certain patients (e.g., elderly, volume-depleted, or when combining with other agents); many patients are maintained on 50 mg once daily or titrated up to 100 mg once daily based on response.
-
For renal protection in diabetes with proteinuria: lower doses may be used initially and adjusted according to guidelines and patient response; monitor renal function and potassium.
-
Administration: take losartan by mouth, with or without food, at the same time each day to maintain steady drug levels. Swallow tablets whole with water.
-
Missed dose: if you miss a dose, take it as soon as you remember on the same day. Do not double the next dose to make up for a missed dose.
-
Do not stop suddenly without consulting your healthcare provider; blood pressure may rise again.
Quick Tips for Patients
-
Measure blood pressure regularly at home and keep a log to show your clinician.
-
Stand up slowly from sitting or lying positions to reduce dizziness from low blood pressure.
-
Avoid salt substitutes that contain potassium or potassium supplements unless advised and monitored by your doctor.
-
Inform all healthcare providers (dentists, surgeons) that you are taking losartan, especially before procedures that may involve changes in fluid status or anesthesia.
-
Carry a list of your medications and known allergies; include over-the-counter medicines and herbal products.
-
If you experience symptoms such as fainting, severe lightheadedness, swelling of face or throat, difficulty breathing, or signs of high potassium (muscle weakness, palpitations), seek medical attention immediately.
Drug Interactions
Losartan can interact with several medicines and substances. Key interactions to be aware of include:
-
Other RAAS blockers (ACE inhibitors, other ARBs, aliskiren): combining increases risk of hypotension, kidney dysfunction, and hyperkalemia. Concurrent use is generally avoided unless under specialist supervision.
-
Potassium‑sparing diuretics (spironolactone, eplerenone, amiloride, triamterene), potassium supplements, or salt substitutes containing potassium: increased risk of hyperkalemia — monitor potassium closely or avoid combination.
-
Nonsteroidal anti‑inflammatory drugs (NSAIDs) and COX-2 inhibitors: may reduce antihypertensive effect and increase risk of kidney injury, especially in patients with volume depletion or preexisting renal impairment.
-
Diuretics and other antihypertensives: additive blood pressure–lowering effects; monitor for symptomatic hypotension when starting or adjusting doses.
-
Lithium: ARBs can increase lithium levels and toxicity; monitor lithium concentrations if combined and adjust dose as needed.
-
CYP enzyme interactions: losartan is metabolized partly by CYP2C9 and CYP3A4 to an active metabolite. Strong inhibitors or inducers of these enzymes may alter levels, though clinically significant interactions are relatively uncommon at usual doses. Examples: rifampicin (inducer), some azole antifungals (inhibitors), certain anticonvulsants (carbamazepine) — monitor clinical response.
Always tell your prescriber about all prescription and over-the-counter medicines, vitamins, and herbal supplements you take. Your clinician will decide whether any combinations are safe and whether monitoring or dose adjustments are needed.
When to Contact a Healthcare Provider
-
Symptoms of low blood pressure: fainting, prolonged dizziness, severe lightheadedness.
-
Signs of allergic reaction or angioedema: swelling of face, lips, tongue, throat, difficulty breathing or swallowing — seek emergency care.
-
Marked decrease in urine output, sudden swelling of legs, rapid weight gain, or symptoms suggesting worsening kidney function.
-
Muscle weakness, irregular heartbeat, or other signs that could indicate high potassium.
Laboratory Monitoring
Baseline and periodic monitoring typically include blood pressure, renal function (serum creatinine), and serum electrolytes (potassium). Frequency depends on patient risk factors: check within 1–2 weeks after initiating therapy or after dose increases in at-risk patients, then periodically as clinically indicated.
| Product Name | Losartan Tablets |
| Category | All Medicines, Cardiac / Hypertension |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 25mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
